Clinical Trial Update: Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating preoperative combination therapy with everolimus and letrozole for primary breast cancer in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)
• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED